Royal Dental College

Diabetes mellitus is a prevalent chronic disorder characterized by elevated blood glucose levels resulting from inadequate insulin production or utilization. The rising global incidence, particularly in developing countries, underscores the urgent need for alternative therapeutic options beyond conventional treatments, which often have undesirable side effects and high costs. Natural plant-based remedies, such as fenugreek (Trigonella foenum-graecum L), have garnered attention due to their promising glycemic control properties. Rich in dietary fibers, phytochemicals, and bioactive compounds including galactomannan, fenugreek exhibits multifaceted therapeutic effects, including anti-diabetic, anti-inflammatory, and antioxidant activities. The primary mechanisms involve delaying gastric emptying, inhibiting carbohydrate absorption, and enhancing insulin secretion and sensitivity. Preclinical studies in rodents demonstrate fenugreek’s capacity to improve blood glucose and lipid profiles, alongside promoting beneficial modulation of gut microbiota. Human trials suggest that fenugreek’s soluble fiber, particularly galactomannan, significantly lowers fasting blood glucose levels. However, despite encouraging results, most evidence remains from animal models, and comprehensive clinical trials are needed to establish optimal dosages, long-term safety, and mechanisms of action conclusively. Understanding fenugreek’s therapeutic potential could provide a cost-effective, natural adjunct or alternative to existing anti-diabetic medications, contributing to better management of blood glucose and reducing diabetic complications. Continued research and standardized human studies are essential to transitioning fenugreek-based therapies from experimental to mainstream clinical use.